樂
樂觀
樂觀 · 25%DNA
$11.62
情境價格
$9.710
-0.291 (-3.00%)收盤時
Loading chart…
- 最高
- 10.140
- 開盤
- 9.690
- 成交量加權均價
- 9.78
- 成交量
- 1.98M
- 市值
- 683.73M
- 最低
- 9.500
- 成交金額
- 19.36M
- 企業價值/稅息折舊攤銷前利潤（TTM）
- -4.49
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.
AI 分析 of Ginkgo Bioworks Holdings Inc (DNA)
賣出Ginkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $10.27, and the company reported a staggering 21% decline over the last five days. Additionally, the RSI is at 35.487, indicating oversold conditions but also reflecting weak momentum. The recent downgrade by TD Cowen, coupled with insider selling increasing by 74248.78%, suggests a lack of confidence in the company's near-term growth prospects, making it a risky investment at this time.
分析師評級（2）
上檔空間 +23.58%
賣出
0 買進
0 持有
2 賣出
目前: 9.71
最低
12.00
平均
12.00
最高
12.00
TD Cowen
持有
$9
2026-08-07
TD Cowen
2026-08-07
目標價
$9
持有
BTIG
賣出
$5
2026-03-12
BTIG
2026-03-12
目標價
$5
賣出
TD Cowen
買進
$12
2026-01-08
TD Cowen
2026-01-08
目標價
$12
買進
BTIG
賣出
$9
2025-08-25
BTIG
2025-08-25
目標價
$9
賣出
TD Cowen
買進
$16
2025-08-08
TD Cowen
2025-08-08
目標價
$16
買進
估值指標
Ginkgo Bioworks Holdings Inc（DNA）目前預期本益比為 0.00，5 年平均預期本益比為 -6.41。
Alphio AI 對 DNA 的價格情境
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。
持有 DNA 的大戶
事件時間軸
資訊
7.510-09PRnewswireGinkgo Integrates Araceli's High-Throughput Imaging Technology
7.510-08NewsfilterGinkgo Bioworks Supports NSF X-Labs Program with Autonomous Lab Access
7.510-08PRnewswireGinkgo Bioworks Integrates Araceli's High-Throughput Imaging Technology
7.510-08PRnewswireAraceli and Ginkgo Enhance Cellular Imaging Capabilities
7.510-08PRnewswireGinkgo Integrates Araceli's Endeavor for Enhanced Cellular Data Generation
DNA 常見問題 —— 由 Alphio AI 解答
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Ginkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $10.27, and the company reported a staggering 21% decline over the last five days. Additionally, the RSI is at 35.487, indicating oversold conditions but also reflecting weak momentum. The recent downgrade by TD Cowen, coupled with insider selling increasing by 74248.78%, suggests a lack of confidence in the company's near-term growth prospects, making it a risky investment at this time.
2 analysts cover DNA: 0 rate it Buy, 0 Hold and 2 Sell. The average price target is 12.00.
社群
更多 ↗
$RT1 $DOGE 🚨 DNA IS TESTING A MAJOR RESISTANCE...... A BREAKOUT COULD CHANGE THE PICTURE! 📈 $DNA Buyers have stepped back in, and RSI(6) near 55 suggests mildly bullish momentum. However, the recent rejection near $0.22011 shows that sellers are still defending higher prices. 📈 If buyers break above $0.22011 with strong volume, the price could move toward $0.23180. But if resistance holds and momentum fades, DNA may pull back toward $0.19120, with $0.17168 as the key support to watch. 👀 Key levels to watch: 🟢 Support: $0.19120 – $0.17168 🔴 Resistance: $0.22011 – $0.23180 ⚠️ Don’t mistake a bounce for a confirmed breakout. Wait for confirmation and always manage your risk. $DNA
展開
$DNA DUMPS 27% | BEARISH TARGET IN SIGHT My October 19 bearish setup on #DNA continues to play out, with price now down to $0.19074, a ~27% drop from our short setup's breakdown exit point. Updated Technical Analysis: ➤ Current Price: $0.19074 ➤ Bearish Target: $0.148 ➤ Key Resistance: $0.250 ➤ Bearish Outlook: Still watching for further downside toward $0.148. The chart is doing the talking. Hope you're enjoying the analysis. Stay tuned for the next update.
展開
Gate Futures Listings | October 12–18, 2026 One-stop access to popular memes, crypto assets, stocks, and ETFs. 🔹 New: 14 futures trading pairs. As of now, Gate supports trading 482+ stock futures. 🔹 Last week's highlights: $DNA, $BATON, $CLAUDIA, $SBUX, and other futures tokens. 🔹 Long and short positions support up to 20x leverage, helping you respond flexibly to market conditions. 🔹 Join popular futures events to earn more rewards. Stock Futures Bonus Season: Share a 500,000 USDT prize pool, with up to 1,000 USDT per person. ChangXin Memory and Unitree Robotics futures trading competition: register to receive 5 USDT, with up to 240 USDT per person.
展開
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。